Addus HomeCare Corporation $ADUS Holdings Lowered by Great Lakes Advisors LLC

Key Points

• Great Lakes Advisors LLC reduced its holdings in Addus HomeCare by 23.9%, selling 6,539 shares and now owning about 0.11% of the company valued at approximately $2.06 million.
• Addus HomeCare reported $1.49 earnings per share for the last quarter, exceeding expectations, with revenue increasing by 21.8% year-over-year to $349.44 million.
• Analysts have mixed ratings on Addus HomeCare, with price targets ranging from $83 to $150, and an average target price of $138.89.

Great Lakes Advisors LLC reduced its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 23.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,835 shares of the company's stock after selling 6,539 shares during the period. Great Lakes Advisors LLC owned 0.11% of Addus HomeCare worth $2,060,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Premier Fund Managers Ltd purchased a new position in shares of Addus HomeCare during the 1st quarter worth about $726,000. Deutsche Bank AG lifted its holdings in shares of Addus HomeCare by 50.0% during the 4th quarter. Deutsche Bank AG now owns 16,354 shares of the company's stock worth $2,050,000 after acquiring an additional 5,448 shares during the period. Punch & Associates Investment Management Inc. lifted its holdings in shares of Addus HomeCare by 2.1% during the 1st quarter. Punch & Associates Investment Management Inc. now owns 110,286 shares of the company's stock worth $10,906,000 after acquiring an additional 2,260 shares during the period. Bank of America Corp DE lifted its holdings in shares of Addus HomeCare by 273.6% during the 4th quarter. Bank of America Corp DE now owns 175,070 shares of the company's stock worth $21,945,000 after acquiring an additional 128,211 shares during the period. Finally, HighTower Advisors LLC raised its holdings in Addus HomeCare by 62.4% in the first quarter. HighTower Advisors LLC now owns 4,671 shares of the company's stock valued at $462,000 after buying an additional 1,795 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $114.95, for a total transaction of $2,873,750.00. Following the completion of the transaction, the chief executive officer directly owned 166,461 shares of the company's stock, valued at approximately $19,134,691.95. This trade represents a 13.06% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Brian Poff sold 7,739 shares of the business's stock in a transaction on Monday, August 25th. The stock was sold at an average price of $116.82, for a total value of $904,069.98. Following the completion of the sale, the executive vice president directly owned 56,980 shares in the company, valued at $6,656,403.60. This represents a 11.96% decrease in their position. The disclosure for this sale can be found here. Insiders sold 34,310 shares of company stock worth $3,958,375 over the last ninety days. Company insiders own 4.50% of the company's stock.

Addus HomeCare Stock Performance

Addus HomeCare stock traded down $0.67 during mid-day trading on Tuesday, reaching $108.60. The company's stock had a trading volume of 34,353 shares, compared to its average volume of 184,755. The firm has a market cap of $2.00 billion, a price-to-earnings ratio of 23.97, a PEG ratio of 1.68 and a beta of 0.85. The business has a 50 day moving average price of $111.95 and a 200-day moving average price of $107.38. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.17. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Monday, August 4th. The company reported $1.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.45 by $0.04. The company had revenue of $349.44 million for the quarter, compared to analysts' expectations of $345.71 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The firm's quarterly revenue was up 21.8% compared to the same quarter last year. During the same period last year, the business posted $1.35 earnings per share. Sell-side analysts predict that Addus HomeCare Corporation will post 4.59 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts recently commented on ADUS shares. Royal Bank Of Canada raised their price target on shares of Addus HomeCare from $133.00 to $134.00 and gave the company an "outperform" rating in a report on Friday, August 22nd. Stephens restated an "overweight" rating and issued a $140.00 price target on shares of Addus HomeCare in a report on Wednesday, September 3rd. JMP Securities restated a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a report on Wednesday, July 16th. Wall Street Zen upgraded shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday, June 29th. Finally, TD Cowen raised their price target on shares of Addus HomeCare from $135.00 to $139.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Two investment analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, Addus HomeCare has an average rating of "Buy" and a consensus target price of $138.89.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.